Dose Adjustment for Subtherapeutic Phenytoin Level
The phenytoin dose must be significantly increased, as the current level of 3.6 µg/mL is critically subtherapeutic and places the patient at high risk for breakthrough seizures. The therapeutic range for total serum phenytoin is 10-20 µg/mL 1, and this patient is receiving inadequate seizure control at less than half the minimum therapeutic concentration.
Immediate Action Required
Increase the daily dose substantially - the current regimen of 200 mg twice daily (400 mg/day total) is insufficient. Based on FDA labeling, most adults require 300-400 mg daily for maintenance, with some requiring up to 600 mg daily (two capsules three times daily) 1.
Recommended Dosing Strategy
Given the severely low level, consider these approaches:
- Incremental increase: Increase to 300 mg twice daily (600 mg/day total) initially, then recheck level in 5-7 days after steady state
- Alternative: Increase to 200 mg three times daily (600 mg/day total) for better distribution throughout the day
- The FDA label indicates satisfactory maintenance for most adults is one capsule (100 mg) three to four times daily, with increases up to two capsules three times daily if necessary 1
Critical Pharmacokinetic Considerations
Exercise caution with dose escalation due to phenytoin's non-linear (Michaelis-Menten) kinetics 2. Small dose increases can produce disproportionately large increases in serum concentration once levels approach 10 µg/mL. Research demonstrates that when concentrations reach 5-10 µg/mL, dose adjustments should be made in small increments of approximately 25-50 mg 2.
Monitoring Plan
- Recheck serum phenytoin level 5-7 days after dose adjustment (after reaching steady state)
- Obtain trough level (just before next scheduled dose) for optimal interpretation 1
- Check serum albumin - if albumin is low (<3.5 g/dL), calculate adjusted phenytoin using the Sheiner-Tozer equation, as total phenytoin may underestimate free (active) drug concentration 3
Common Pitfalls to Avoid
- Do not make small incremental changes (e.g., 50 mg increases) when the level is this profoundly low - you need a substantial increase
- Do not wait weeks between adjustments - the patient is at significant risk for seizures with this subtherapeutic level
- Do not assume non-compliance without investigation - verify the patient is actually taking the medication as prescribed
- Be aware that once levels approach therapeutic range, phenytoin exhibits saturable kinetics where small dose changes can cause large concentration changes 2
- Consider drug interactions that may be reducing phenytoin levels (carbamazepine can decrease levels 4)
Alternative Consideration
If compliance is confirmed and levels remain low despite appropriate dosing, consider checking a free phenytoin level to assess for altered protein binding, particularly if albumin is low 3.